Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition.
about
Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor ImmunityAging affects AO rat splenic conventional dendritic cell subset composition, cytokine synthesis and T-helper polarizing capacityp38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression.CD14(+) macrophage-like cells as the linchpin of cervical cancer perpetrated immune suppression and early metastatic spread: A new therapeutic lead?Rationale for the design of an oncology trial using a generic targeted therapy multi‑drug regimen for NSCLC patients without treatment options (Review)The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9.Tumor-altered dendritic cell function: implications for anti-tumor immunity.Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and Suppression.Tumor-derived factors modulating dendritic cell function.Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model.Functional characterization of a STAT3-dependent dendritic cell-derived CD14(+) cell population arising upon IL-10-driven maturation.Improvement of cancer immunotherapy by combining molecular targeted therapy.Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14(+) PD-L1(+) phenotype in prostate cancer.Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells.Human Chorionic Villous Mesenchymal Stem Cells Modify the Functions of Human Dendritic Cells, and Induce an Anti-Inflammatory Phenotype in CD1+ Dendritic Cells.Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy.Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics.Recent advances in understanding dendritic cell development, classification, and phenotype
P2860
Q28075996-0D95C909-5FA3-4D2E-86B2-022FC982258BQ28573902-35388DF7-F036-4F2C-9B10-C18BED8A2D94Q30422500-1A91C58E-7F94-458B-8211-9C6DC2B770D9Q35799091-C11ABF24-18FB-498D-8526-01703E690952Q37260992-EB11941C-B500-4A55-8E21-88FC7FE1F584Q37600827-51576318-98C1-4D46-927F-9AB553EAA459Q38123166-7E0444E1-8C1F-4212-AE85-73C8EEAEDF45Q38170109-C0C6983B-7092-487E-A103-10DC93B9D436Q38777795-F879176B-23B4-433E-B066-AAA06603B587Q38962315-3D44C393-4889-4014-A269-2F47230FDDC2Q40118206-654DC714-5DE5-449D-80A0-C2CFB0BC01C8Q40725616-D701EE95-BA39-498B-84DC-2877C8A6459AQ41075854-85D09187-9310-4D8C-88CD-215D0AE7FE03Q42476576-FCA4A6E6-3F3E-4A49-8AEE-5C90AB43CD43Q47135720-CCE4EDDA-3165-414A-890E-3B81991E28C3Q47868110-48FEA28A-F04B-4C45-ABE0-2845FB82DFF3Q50630386-B2726467-4ACA-4F97-A9F5-ED6F33E7BC3BQ52327450-EF08C1C7-B8DE-41BB-B575-843F53D1CCBEQ55217703-7DCACDD8-85FE-40EB-8433-CD838C3F5675Q57821272-C3280279-9EB6-4FED-99BB-AE0FC91C31F7
P2860
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tumor-mediated inhibition of h ...... p38 MAPK and STAT3 inhibition.
@en
Tumor-mediated inhibition of h ...... p38 MAPK and STAT3 inhibition.
@nl
type
label
Tumor-mediated inhibition of h ...... p38 MAPK and STAT3 inhibition.
@en
Tumor-mediated inhibition of h ...... p38 MAPK and STAT3 inhibition.
@nl
prefLabel
Tumor-mediated inhibition of h ...... p38 MAPK and STAT3 inhibition.
@en
Tumor-mediated inhibition of h ...... p38 MAPK and STAT3 inhibition.
@nl
P2093
P2860
P356
P1433
P1476
Tumor-mediated inhibition of h ...... p38 MAPK and STAT3 inhibition.
@en
P2093
Alfons J M van den Eertwegh
Basav Hangalapura
Dinja Oosterhoff
Hester van Cruijsen
Jelle Lindenberg
Lotte Hiddingh
Rieneke van de Ven
Rik J Scheper
Sinéad Lougheed
P2860
P304
P356
10.4161/ONCI.20365
P577
2012-08-01T00:00:00Z